• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    OHA is Administrative Agent and Lead Left Arranger of Private Debt Financing Supporting Montagu's Acquisition of Tyber Medical

    6/18/25 8:00:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance
    Get the next $TROW alert in real time by email

    New York, New York, June 18, 2025 (GLOBE NEWSWIRE) -- Oak Hill Advisors ("OHA") served as Administrative Agent and Lead Left Arranger for the private senior debt financing supporting the acquisition of Tyber Medical, LLC ("Tyber Medical") by Montagu Private Equity ("Montagu"). Tyber Medical is a leading orthopedic device manufacturer serving the spine and trauma end markets.

    As part of the transaction, Montagu will merge Tyber Medical with two of its existing portfolio companies, Resolve Surgical Technologies ("Resolve") and Intech Medical ("Intech"), to create a scaled contract development and manufacturing organization ("CDMO") offering end-to-end services that span product conceptualization, development, manufacturing and regulatory approval for advanced surgical systems. OHA is one of the largest holders across the new first lien facility.

    OHA's comprehensive understanding of CDMOs, having invested in several leading private and public companies within the market, positioned it to diligence the financing opportunity with speed and certainty.

    "We are pleased to partner with Montagu as a leading investment firm with a proven track record of investing across the healthcare ecosystem and driving growth within its portfolio companies," said Eric Muller, Partner and Portfolio Manager at OHA. "Our deep history of investing in CDMOs allowed us to quickly gain conviction in each of Tyber Medical, Resolve and Intech, and we look forward to supporting the accelerated advancements within orthopedics that we believe will be driven by the scale and domain expertise of the combined business."

    "We are delighted to establish this new debt financing and to partner with our lender group, led by OHA," said Henry Johnson, Partner and Head of Capital Markets at Montagu. "The transaction will support the business's strategic initiatives and represents another successful capital markets execution in the U.S. for Montagu."

    Rothschild & Co served as financial advisor to Montagu for the debt financing transaction.

    BMO Capital Markets also participated in this financing as OHA's private credit joint venture partner.

    ###

    About OHA: Oak Hill Advisors (OHA) is a leading global credit-focused alternative asset manager with over 30 years of investment experience. OHA works with institutions and individuals and seeks to deliver a consistent track record of attractive risk-adjusted returns. The firm has approximately $95 billion in assets under management (AUM) across credit strategies, including private credit, high yield bonds, leveraged loans, private capital solutions and collateralized loan obligations as of March 31, 2025. Additional information on OHA's AUM calculation methodology can be found on the OHA website. OHA's emphasis on long-term partnerships with companies, sponsors and other partners allows for the provision of customized credit solutions across market cycles.

    With over 400 experienced professionals across six global offices, OHA brings a collaborative approach to offering investors a single platform to meet their diverse credit needs. OHA is the private markets platform of T. Rowe Price Group, Inc. (NASDAQ – GS: TROW). For more information, please visit www.oakhilladvisors.com.

    About Tyber Medical, LLC: Tyber Medical, LLC is a leading orthopedic device manufacturer providing rapid access to FDA-cleared and CE-marked, private label, portfolio-enhancing regulatory-approved orthopedic implants for the spinal, extremity, and trauma markets. Since its founding in 2012, the company has released more than 50 spine, extremity, and trauma systems. Tyber Medical aims to develop and utilize differentiated bioengineered technologies, including surface treatments and coatings, to advance orthopedic science. For more information, visit https://tybermedical.com.

    About Montagu: Montagu is a leading mid-market private equity firm, committed to finding and growing businesses that make the world work. Focusing on businesses with a must-have product or service in a structurally growing marketplace, Montagu brings proven growth capabilities to help companies achieve their ambitions and unlock their full potential. Montagu specializes in carve-out and other first time buyout investments and has deep expertise in five priority sectors: Healthcare, Financial Sector Services, Critical Data, Digital Infrastructure and Education. ESG forms an integral part of its strategy, and its commitment to responsible investment is fully integrated into its investment and value-creation process. Montagu partners with companies with enterprise values between €200 million and €1 billion and has €14 billion of assets under management.



    Natalie Harvard, Head of Investor Relations & Partner
    Oak Hill Advisors, L.P.
    212-326-1505
    [email protected]
    
    Kristin Celestino, Vice President, Branding
    Oak Hill Advisors, L.P.
    817-215-2934
    [email protected]
    
    Get the next $TROW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TROW

    DatePrice TargetRatingAnalyst
    9/12/2024$109.00Equal Weight
    Wells Fargo
    8/27/2024$99.00Underweight
    Barclays
    4/11/2024$106.00 → $120.00Underperform → Mkt Perform
    Keefe Bruyette
    4/8/2024$92.00 → $114.00Sell → Hold
    TD Cowen
    1/8/2024$95.00 → $105.00Equal Weight → Underweight
    Wells Fargo
    1/4/2024$88.00Underperform
    TD Cowen
    10/31/2023$100.00 → $95.00Sell → Neutral
    Citigroup
    5/19/2023$98.00Sell
    Citigroup
    More analyst ratings

    $TROW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Wells Fargo initiated coverage on T. Rowe Price with a new price target

      Wells Fargo initiated coverage of T. Rowe Price with a rating of Equal Weight and set a new price target of $109.00

      9/12/24 9:14:34 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • Barclays initiated coverage on T. Rowe Price with a new price target

      Barclays initiated coverage of T. Rowe Price with a rating of Underweight and set a new price target of $99.00

      8/27/24 7:37:56 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • T. Rowe Price upgraded by Keefe Bruyette with a new price target

      Keefe Bruyette upgraded T. Rowe Price from Underperform to Mkt Perform and set a new price target of $120.00 from $106.00 previously

      4/11/24 8:03:23 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance

    $TROW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Vice President Page Sebastien exercised 17,059 shares at a strike of $69.02 and covered exercise/tax liability with 14,300 shares, increasing direct ownership by 4% to 64,375 units (SEC Form 4)

      4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

      6/20/25 9:49:08 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • VP Sawyer Dorothy C sold $190,860 worth of shares (2,000 units at $95.43), decreasing direct ownership by 4% to 44,789 units (SEC Form 4)

      4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

      6/12/25 9:20:18 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • VP Sawyer Dorothy C was granted 78 shares and gifted 267 shares, decreasing direct ownership by 0.40% to 46,789 units (SEC Form 4)

      4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

      6/5/25 10:26:28 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance

    $TROW
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OHA is Administrative Agent and Lead Left Arranger of Private Debt Financing Supporting Montagu's Acquisition of Tyber Medical

      New York, New York, June 18, 2025 (GLOBE NEWSWIRE) -- Oak Hill Advisors ("OHA") served as Administrative Agent and Lead Left Arranger for the private senior debt financing supporting the acquisition of Tyber Medical, LLC ("Tyber Medical") by Montagu Private Equity ("Montagu"). Tyber Medical is a leading orthopedic device manufacturer serving the spine and trauma end markets. As part of the transaction, Montagu will merge Tyber Medical with two of its existing portfolio companies, Resolve Surgical Technologies ("Resolve") and Intech Medical ("Intech"), to create a scaled contract development and manufacturing organization ("CDMO") offering end-to-end services that span product conceptua

      6/18/25 8:00:00 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER

      The T. Rowe Price Financials ETF, Health Care ETF and Natural Resources ETF began trading today and expanded the firm's ETF lineup to 22 BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds (ETF): T. Rowe Price Financials ETF (Ticker: TFNS), T. Rowe Price Health Care ETF (Ticker: TMED), and T. Rowe Price Natural Resources ETF (Ticker: TURF). The new funds began trading on NASDAQ today. T. Rowe Price's active ETF roster now sits at 22 offerings.

      6/12/25 10:05:00 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • T. ROWE PRICE RELEASES 2025 MIDYEAR INVESTMENT OUTLOOK

      Investing in a post-globalization world with reconfigured global trade necessitates a careful assessment of market opportunities and risks BALTIMORE, June 9, 2025 /PRNewswire/ -- T. Rowe Price, a global investment management firm and a leader in retirement, released its midyear outlook for global financial markets for the remainder of 2025. Underpinning the outlook for the next six months is an accelerated trend toward deglobalization, a tariff-driven reconfiguration of global trade, an expected broadening of stock market opportunities globally beyond U.S. equities and mega-cap tech stocks, and a bond market regime change driven by trade policy changes and German fiscal expansion.

      6/9/25 1:00:00 PM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance

    $TROW
    SEC Filings

    See more
    • SEC Form 144 filed by T. Rowe Price Group Inc.

      144 - PRICE T ROWE GROUP INC (0001113169) (Subject)

      5/13/25 9:39:46 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • T. Rowe Price Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - PRICE T ROWE GROUP INC (0001113169) (Filer)

      5/12/25 9:24:54 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form 10-Q filed by T. Rowe Price Group Inc.

      10-Q - PRICE T ROWE GROUP INC (0001113169) (Filer)

      5/2/25 11:44:44 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance

    $TROW
    Leadership Updates

    Live Leadership Updates

    See more
    • T. ROWE PRICE GROUP, INC., DECLARES QUARTERLY DIVIDEND AND ANNOUNCES ANNUAL MEETING VOTING RESULTS

      BALTIMORE, May 9, 2025 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced today that its Board of Directors has declared a quarterly dividend of $1.27 per share payable June 27, 2025, to stockholders of record as of the close of business on June 13, 2025. Additionally, at its annual meeting yesterday, T. Rowe Price Group, Inc.'s stockholders: Elected 11 directors to its Board of Directors;Approved, by a nonbinding advisory vote, the compensation paid by the Company to its Named Executive Officers;Ratified the appointment of KPMG LLP as the Company's indepen

      5/9/25 1:25:00 PM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • BBSI Appoints Mark S. Finn to its Board of Directors

      VANCOUVER, Wash., April 07, 2025 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (BBSI) (NASDAQ:BBSI), a leading provider of business management solutions and one of the largest professional employer organizations (PEO) in the U.S., has appointed Mark S. Finn to its board of directors, effective April 7, 2025. Finn spent over 30 years with T. Rowe Price Group (NASDAQ:TROW), a global investment management firm, where he held several roles, including portfolio manager of the firm's $35 billion US Value Equity Strategy Fund and co-portfolio manager of its $3.5 billion US Large-Cap Value Equity Strategy Fund. Before T. Rowe Price, Finn worked in assurance services at Price Waterhouse & Co

      4/7/25 4:05:00 PM ET
      $BBSI
      $TROW
      Professional Services
      Consumer Discretionary
      Investment Bankers/Brokers/Service
      Finance
    • Ingersoll Rand Appoints Michelle Swanenburg to Board of Directors

      DAVIDSON, N.C., April 03, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and life sciences and industrial solutions, today announced the appointment of Michelle Swanenburg to its Board of Directors, effective immediately. Swanenburg currently serves as the head of Human Resources (HR) at T. Rowe Price (NASDAQ:TROW), a premier global asset management organization with $1.63 trillion in assets under management as of February 28, 2025. She brings over twenty years of experience as a strategic and accomplished HR leader, with a proven track record of leading growth and innovation by continually improving strategies focused on peop

      4/3/25 8:30:00 AM ET
      $IR
      $TROW
      Industrial Machinery/Components
      Industrials
      Investment Bankers/Brokers/Service
      Finance

    $TROW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by T. Rowe Price Group Inc. (Amendment)

      SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)

      2/13/24 4:55:53 PM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13G/A filed by T. Rowe Price Group Inc. (Amendment)

      SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)

      1/29/24 12:09:07 PM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13G/A filed by T. Rowe Price Group Inc. (Amendment)

      SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)

      2/10/23 12:26:32 PM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance

    $TROW
    Financials

    Live finance-specific insights

    See more
    • T. ROWE PRICE GROUP DECLARES QUARTERLY DIVIDEND

      BALTIMORE, Nov. 1, 2024 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced today that its Board of Directors has declared a quarterly dividend of $1.24 per share payable December 27, 2024, to stockholders of record as of the close of business on December 13, 2024. ABOUT T. ROWE PRICEFounded in 1937, T. Rowe Price (NASDAQ – GS: TROW) helps individuals and institutions around the world achieve their long-term investment goals. As a large global asset management company known for investment excellence, retirement leadership, and independent proprietary research, the firm is built on a culture of integrity that puts client interests first. Clients rely on the award-winning f

      11/1/24 2:35:00 PM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • T. ROWE PRICE GROUP DECLARES QUARTERLY DIVIDEND

      BALTIMORE, July 30, 2024 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced today that its Board of Directors has declared a quarterly dividend of $1.24 per share payable September 27, 2024, to stockholders of record as of the close of business on September 13, 2024. ABOUT T. ROWE PRICEFounded in 1937, T. Rowe Price (NASDAQ – GS: TROW) helps individuals and institutions around the world achieve their long-term investment goals. As a large global asset management company known for investment excellence, retirement leadership, and independent proprietary research, the firm is built on a culture of integrity that puts client interests first. Clients rely on the award-winnin

      7/30/24 5:35:00 PM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance
    • T. ROWE PRICE LAUNCHES CAPITAL APPRECIATION AND INCOME FUND

      New mutual fund adds to the T. Rowe Price Capital Appreciation suite and is led by award-winning portfolio manager David Giroux and Farris Shuggi BALTIMORE, Nov. 29, 2023 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the launch of the Capital Appreciation and Income Fund. The fund is an addition to the Capital Appreciation suite and seeks to generate strong risk-adjusted total returns through a combination of capital appreciation primarily from stocks, income from stock dividends, and interest income from the fund's fixed income holdings. The Capital Appreciation and Income Fund is one of three vehicles within the Capital Appreciation

      11/29/23 9:30:00 AM ET
      $TROW
      Investment Bankers/Brokers/Service
      Finance